New search | Conferencedetail
mail
Print view
 
 

3rd ALS Drug Development Summit 2024

Evvnt Promotion / evvnt
-
21.05.2024 - 23.05.2024  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
 
Conference themes
Identify Transformative ALS Targets, Seek Translational Biomarkers and Propel More Clinical Approvals

Following monumental progress in 2023, the ALS treatment landscape is surging with novel innovation to navigate the complex, multifactorial nature of motor neuron degeneration and develop more truly transformative drugs for sporadic and familial ALS.
Professional congress organizer (PCO)
Hanson Wade
Notes
URL:
Brochure: https://go.evvnt.com/2215799-3?pid=4832

Speakers: Diego Cadavid Chief Medical Officer Verge Genomics, Disha Sood Senior Scientist Sanofi , Emily Caporello Director, Small Business Program NINDS/NIH , and more
 

Enquiries and Registration:

https://go.evvnt.com/2215799-2?pid=4832
Ms. Erin Thomas
 
Categories
General Medicine
Languages
English
Congress fees
Industry Pricing - Conference + Workshop Day: USD 3597.00, Industry Pricing - Conference Only: USD 2599.00, Service Provider Pricing - Conference + Workshop Day: USD 5197.00, Service Provider Pricing - Conference Only: USD 3699.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AMREF - African Medical and Research FoundationEuropean Public Health Association (EUPHA)newTreeHilfswerk AustriaÖsterreichische Akademie der ÄrzteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioSwiss Tropical and Public Health InstituteAlumni Club Medizinische Universität Wien